An Assessment of the Prevalence, Determinants of Viral Hepatitis B and Impact of Infant Vaccine and Circumcision as Preventive Measures in Malawi
Abstract:
Hepatitis B virus is one of the neglected public health diseases leading to deaths in Malawi. However, few studies have examined the burden and factors associated with disease acquisition. The study aimed to assess the prevalence of hepatitis B infection and the factors associated with it in the Malawian population. This retrospective study used secondary data from the scan form register, pulling and analysing data from Jan 2023 to July 2025. Out of 1.9 million total tests, 1.6% (32566) were hepatitis B positive. Hepatitis B burden among males and non-pregnant females was 2.4% (14839/611,970). Males had a higher prevalence of 3% (9,873/334,299) than non-pregnant females at 1.7% (4962/284958). Bivariate analysis showed that males were twice as likely to have hepatitis B compared to females OR = 2, p < 0. 0001. Infant-vaccinated clients were 77% less likely to be infected than the non-vaccinated (OR = 0.3, p < 0.0001). Pregnant women were less likely to be hepatitis B infected than non-pregnant women (OR = 0.8, P < 0.001). The study reveals that hepatitis B is less prevalent than in earlier studies done in Malawi. The Infant Vaccine seems effective in reducing hepatitis B infection among infants who receive this vaccine. Male gender, not being pregnant, and being circumcised increased the risk for hepatitis B infection. Further studies need to be carried out to study the role of circumcision and the association between pregnancy and Viral hepatitis.References:
[1].
WHO. Global Health Sector Strategy on Viral Hepatitis. 2017. Retrieved
from https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.who.int/publications/i/item/WHO-HIV-2016.06&ved=2ahUKEwinx6bZntSSAxWaUUEAHSsmFPMQFnoECBkQAQ&usg=AOvVaw2vBP3RwvcUzt_hFdCHkGQl
[2].
WHO. Global burden of diseases causes-Africa Region. Geneva: Lancent;
2018. Retrieved from https://www.afro.who.int/health-topics/hepatitis
[3].
Lemoine M. Battlefield against hepatitis B infection and HCC in Africa.
Journal of Hepatolgy. 2017;66(3). doi:https://doi.org/10.1016/j.jhep.2016.10.013
[4].
O Hara GA, MacNaughton AL, Maponga T, Jooste P. Hepatitis B virus
infection as a neglected tropical disease. plos one. 2017. doi:https://doi.org/10.1371/journal.pntd.0005842
[5].
Spearman WC, Afihene M, Reidwaan A. Hepatitis B in sub-Saharan Africa:
strategies to achieve the 2030 elimination targets. Lancet. 2017. doi:https://doi.org/10.1016/S2468-1253(17)30295-9
[6].
Kilonzo SB, Nkandala I, Rodovick L. Prevalence of Hepatitis B Virus
Infection in Tanzania: A Systematic Review and Meta-Analysis. Pubmed. 2024.
doi:https://doi.org/10.1155/2024/4178240
[7].
Vanikoor MJ, Sinkala E, Kanunga A. Eligibility for hepatitis B antiviral
therapy among adults in the general population in Zambia. Plos one. 2020. doi:https://doi.org/10.1371/journal.pone.0227041
[8].
Mabunda N, Vieira L, Chelene I. Prevalence of hepatitis B virus and
immunity status among healthcare workers in Beira City, Mozambique. Plos One.
2022. doi:https://doi.org/10.1371/journal.pone.0276283
[9].
Nyirenda M, Beadsworth MB, Stephany P, Munthali C. Prevalence of
infection with hepatitis B and C virus and coinfection with HIV in medical
inpatients in Malawi. Journal of Infection. 2008;57(1):72-77. doi:https://doi.org/10.1016/j.jinf.2008.05.004
[10]. Siobhan S, Taha TE, Kumwenda
N. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and
hepatitis B virus infections among male workers at a sugar estate in Malawi.
Pubmed. 2002. doi:https://doi.org/10.1097/00126334-200209010-00012
[11]. Ahmed SD, Cuevas LE, Brabin
BJ. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women.
Journal of Infection. 1998. doi:https://doi.org/10.1016/s0163-4453(98)91983-1
[12]. Chipeta F, Chirambo A, Billiat
E, Isaac T. Hepatitis B virus seroprevalence among Malawian medical students: A
cross-sectional study. PMC. 2017;29(1). doi:10.4314/mmj.v29i1.6
[13]. Stockdale AJ, Mitambo C,
Everet D. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
BMC Infectious Diseases. 2018. doi:https://doi.org/10.1186/s12879-018-3428-7
[14]. Stockdale AJ, Meiring JE,
Shawa IT. Hepatitis B Vaccination Impact and the Unmet Need for Antiviral
Treatment in Blantyre, Malawi. Journal of Infectious Diseases.
2022;266(5):871-880. doi:10.1093/infdis/jiab562
[15]. Mehta K, Marfatia YS, Jain AP.
Male circumcision and Sexually transmitted Infections - An update. epub.
2021;1(42):1-6. doi:https://doi.org/10.4103/ijstd.ijstd_20_21
[16]. Nyamba PK, Agjei R, Sarfo B.
Seroprevalence and factors associated with Hepatitis B virus infection among
students in two senior high schools in the Krachi Nchumuru district in Ghana-A
cross-sectional study. Pubmed. 2023. doi:https://doi.org/10.1186/s13104-023-06624-4
[17]. Mergan P, Mergan B, Djamand G.
HIV, syphilis, and hepatitis B virus infection and male circumcision in five
Sub-Saharan African countries: Findings from the Population-based HIV Impact
Assessment surveys, 2015–2019. Plos One. 2023. doi:https://doi.org/10.1371/journal.pgph.0002326
[18]. Barbosa J, Sahli R, Aubert V.
Demographics and outcomes of hepatitis B and D: A 10-year retrospective
analysis in a Swiss tertiary referral center. Plos One. 2021. doi:https://doi.org/10.1371/journal.pone.0250347
[19]. Riches N, Njawala T, Thom N,
Mkandawire C. P23 The chiwindi study: results from a community-based hepatitis
B serosurvey in Karonga, Malawi. GUT. 2023;72(Suppl 2).2. Retrieved from https://gut.bmj.com/content/72/Suppl_2/A57.2.info
[20]. WHO. Viral hepatitis country profiles. Geneva; 2022. Retrieved from https://data.who.int/dashboards/hepatitis/epidemiology
